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Background: Cobblestone lissencephaly is a severe neuronal migration disorder associated with congenital
muscular dystrophies (CMD) such as Walker-Warburg syndrome, muscle-eye-brain disease, and Fukuyama-type
CMD. In these severe forms of dystroglycanopathy, the muscular dystrophy and other tissue pathology is caused by
mutations in genes involved in O-linked glycosylation of alpha-dystroglycan. While cerebellar dysplasia is a
common feature of dystroglycanopathy, its pathogenesis has not been thoroughly investigated.
Results: Here we evaluate the role of dystroglycan during cerebellar development. Brain-selective deletion of
dystroglycan does not affect overall cerebellar growth, yet causes malformations associated with glia limitans
disruptions and granule cell heterotopia that recapitulate phenotypes found in dystroglycanopathy patients.
Cerebellar pathology in these mice is not evident until birth even though dystroglycan is lost during the second
week of embryogenesis. The severity and spatial distribution of glia limitans disruption, Bergmann glia
disorganization, and heterotopia exacerbate during postnatal development. Astrogliosis becomes prominent at
these same sites by the time cerebellar development is complete. Interestingly, there is spatial heterogeneity in the
glia limitans and granule neuron migration defects that spares the tips of lobules IV-V and VI.
Conclusions: The full spectrum of developmental pathology is caused by loss of dystroglycan from Bergmann glia,
as neither granule cell- nor Purkinje cell-specific deletion of dystroglycan results in similar pathology. These data
illustrate the importance of dystroglycan function in radial/Bergmann glia, not neurons, for normal cerebellar
histogenesis. The spatial heterogeneity of pathology suggests that the dependence on dystroglycan is not uniform.
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Cerebellar histogenesis involves the formation and mi-
gration of several distinct populations of neural cells
over an extended period of time, from late embryogen-
esis well into post-natal development [1]. This intricate
and protracted developmental process renders the cere-
bellum susceptible to a number of insults leading to a
variety of cerebellar disorders. Cobblestone lissencephaly
encompasses a spectrum of brain malformations, includ-
ing cerebellar dysplasia, due to defects in neuronal* Correspondence: steven-moore@uiowa.edu
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reproduction in any medium, provided the ormigration. This brain malformation is found in a clinic-
ally severe subset of congenital muscular dystrophies
(CMDs)—Walker-Warburg syndrome, muscle-eye-brain
disease, and Fukuyama CMD [2,3]. Genetic, pathologic,
and biochemical studies in patients and in mouse models
support the hypothesis that the loss of alpha dystroglycan-
ligand binding underlies the muscle, eye, and brain path-
ology present in these disorders [4-8].
Dystroglycan (DG), a central component of the
dystrophin-glycoprotein complex, is known to contrib-
ute to basement membrane structure and stability through
its function as a receptor for extracellular matrix (ECM)
proteins [9,10]. DG consists of an extracellular α-subunit
linked to a transmembrane β-subunit. α-DG is decoratedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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affinity receptor for ECM proteins such as laminin, agrin,
and perlecan in a variety of tissues including brain
[4,11,12], neurexin and Slit specifically in brain [13,14],
and pikachurin in retina [15]. β-DG completes the link be-
tween the ECM and the intracellular actin cytoskeleton
via its binding to α-DG outside the cell and dystrophin in
the cytosol [16-19].
We previously reported that brain-selective dele-
tion of DG in mice recapitulates some of the brain
malformations characteristic of severe dystroglycanopathy,
including aberrant migration of cortical and cerebellar
neurons, and further showed severely blunted hippo-
campal long-term potentiation in these mice [5]. Sub-
sequent studies of mice with epiblast-specific deletion
of DG resulted in brain and eye malformations that
broadly resemble the clinical spectrum of the human
disease, including neuronal migration errors, hydroceph-
alus, and defects in anterior as well as posterior chambers
of the eye [20]. Our most recent studies have shown DG
is expressed in radial glia during neocortical histogenesis,
and that glial DG is essential for multiple developmental
processes, including maintenance of the basement
membrane integrity, normal radial glia morphology,
organization of neocortical proliferation, and cortical plate
lamination [8]. Moreover, there are distinct functions for
glial and neuronal DG in the cerebrum—glial DG is
critical for laminar development of the forebrain, while
neuronal DG is necessary for proper hippocampal longterm
potentiation [7].
In the developing cerebellum, DG mRNA is detected
in all major cellular populations, including radial glia,
granule cell (GC) precursors, and Purkinje cells (PC) [21],
while its protein expression is prominent in Bergmann glia
(BG) enfeet, perivascular astrocyte endfeet, and PCs in the
adult cerebellum [22]. How its expression in each of these
cell types contributes to cerebellar development is not
clearly understood. Here we show that DG in cerebel-
lar GC and PC is largely dispensable for cerebellar
histogenesis. In contrast, targeting both neurons and
glia for DG deletion during embryonic development
results in widespread, yet heterogeneous GC migra-
tion abnormalities without reducing overall cerebellar
growth. Disruptions in the glia limitans and aberrant
Bergmann glia (BG) organization coincide with GC
migration errors and regions of gliosis, indicating that
normal cerebellar histogenesis is dependent on proper
BG scaffolds, which are achieved through extracellular
interactions between glial α-DG and components of
the ECM. These findings stress the importance of
glial DG in its contribution to the basal lamina integ-
rity during development and show that glial DG and
neuronal DG have different biological functions in the
cerebellum.Methods
Generation of mice
Nestin-Cre/DG-null, PCP2-Cre/DG-null, and malpha6-
Cre/DG-null mice were produced by breeding nestin-
Cre mice (Jackson Labs), PCP2-Cre [23], malpha6-Cre
[24] with dag1 floxed mice as described for GFAP-Cre/
DG-null mice [5]. In brief, floxed DG mice (Dag1lox/lox)
were crossed with mice heterozygous for the floxed al-
lele and expressing Cre recombinase under the control
of different promoters (Cre+/Dag1lox/+) to generate con-
ditional DG-null mice (Cre+/Dag1lox/lox) at an expected
Mendelian occurrence of 25%. Timed pregnancies were
established as previously described in order to obtain
embryos of specific developmental ages [8]. The cellular-
specificity and developmental timing of expression for
each Cre-loxP/DG-null model used in our studies are il-
lustrated in Figure 1. Animal use procedures were ap-
proved by the University of Iowa Institutional Animal
Care and Use Committee.
Histology and immunofluorescence
For routine histology and histochemistry, postnatal mice
were perfused with 4% PFA, then their brains removed
and fixed for at least 24 hr by immersion in 4% PFA.
Embryos and some postnatal mice were euthanized prior
to fixation in Bouin’s solution. Brains were removed
from older mice prior to immersion fixation, while the
entire heads of embryos and younger postnatal mice
were fixed in Bouin’s. Sagittal sections of the brains
or heads were processed into paraffin blocks and sections
cut at 6 μm. Serial sections were stained with hematoxylin
and eosin and evaluated by routine light microscopy.
Digital images were captured on a Zeiss microscope
using standard proprietary software supplied by the
manufacturers.
For immunofluorescence staining, brains were im-
mersion fixed in 4% PFA, cryoprotected through increas-
ing sucrose concentrations (10% to 20% to 30%) and
embedded in OCT. For E14.5 embryos, the entire heads
were fixed and processed for cryosections. Brains were re-
moved from all postnatal mice prior to fixation. Alterna-
tively, some brains were removed from postnatal mice and
frozen without fixation in isopentane precooled with dry
ice to approximately -75°C. Mid-sagittal sections of the
cerebellum were cut on a cryostat at 10 μm, air-dried,
and stored at -80°C prior to use. Stored sections were
equilibrated in PBS at room temperature (RT) for 5 min
and fixed for 10 min in 2% PFA. Sections were then in-
cubated first in blocking solution (PBS containing 5%
NGS, 0.1% Triton-X) for 1 hr, and then incubated with
primary antibodies overnight at 4°C. Finally, sections
underwent incubation with secondary antibodies for
1 hr at RT. Sections stained for BrdU were treated with
2 N HCl at 37°C for 30 min prior to blocking. All sections
Figure 1 Schematic representations of the different cellular-specific conditional dystroglycan-null mice. Drawings illustrating the mouse
cerebellum during embryonic (A) and postnatal development (B), the cellular organization at specified developmental period (A1, A2, B1, B2),
and the localization of each promoter-driven Cre recombinase expression (A2, B2). Timeline of Cre activities is presented in (C). The nestin and
GFAP promoters drive Cre expression in neuronal and glial precursors as early as E10.5 [43] and E13.5 [28], respectively. However, the GFAP
promoter does not express Cre in Purkinje cells [28]. The PCP2-Cre promoter drives Cre expression in Purkinje cells beginning at P6 [23], whereas
the the malpha6 promoter drives Cre expression in granule cells beginning at P4 [24].
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ide to label nuclei. Images were procured on a Zeiss
ImageReady M1 fluorescence microscope. For quantifica-
tion of data, ten images were obtained per section while
three consecutive sections were acquired per animal, and
three animals were considered per experimental group.
Image adjustments and area measurements were done on
Adobe Photoshop. Variabilities among data are expressed
as mean ± SEM. Statistical analysis (one-way ANOVA with
Tukey post-hoc test) was performed using SPSS software
program and p < 0.05 was considered to be statistically
significant.
Electron microscopy
Mouse pups between P0 and P16 were perfused through
the heart left ventricle with 4% PFA prior to brain re-
moval. A 0.1 cm midsagittal slice of the cerebellum
was then immersion fixed in 2.5% glutaraldehyde and fur-
ther processed as an intact slice through osmication,dehydration, and embedment in epon. Selected regions of
the cerebellar slices were cut out of fully polymerized
epon blocks with a jeweler’s saw and glued to blank epon
stubs for sectioning and ultrastructural evaluation.
BrdU labeling
Mice received intraperitoneal injections of bromodeoxyuridine
(BrdU, 50 mg/kg) 30 min prior to euthanasia to assess ex-
ternal granule cell proliferation or several days prior to eu-
thanasia to assess granule cell migration.
Antibodies
The following primary antibodies are used: IIH6 (anti-
αDG [9]), AP83 (anti-βDG [25]), anti-β1Itg [26], anti-
AQP4 (Millipore AB3068), anti-BrdU (Abcam ab6326),
anti-BLBP (Millipore AB9558), anti-calbindin (Millipore
AB1778), anti-collagen IV (Abcam ab19808), anti-GABARA6
(Sigma G5544), anti-GFAP (Sigma G3893), anti-laminin
(Sigma L9393), anti-Kir4.1 (Alomone Labs APC-035), anti-
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anti-pax6 [Developmental Studies Hybridoma Bank (DSHB)
PAX6] anti-perlecan (Millipore MAB1948), anti-shh (Abcam
ab50515), anti-tag1 (DSHB 4D7), and anti-nestin (DSHB
rat-401).
Secondary antibodies used in all experiments are Alexa
Fluor fluorescent dye conjugates (Invitrogen): goat anti-
mouse IgG1, goat anti-mouse IgM, goat anti-rabbit IgG,
and goat anti-rat IgG.
Results
Neuronal dystroglycan is not essential for cerebellar
histogenesis
Dystrolygcan (DG) is broadly expressed in most cellular
populations of the developing cerebellum—pre-migra-
tory granule cells, Purkinje cells, and radial/Bergmann
glia [21]. To evaluate how DG expression in each of the
aforementioned cell types contributes to cerebellar histo-
genesis, we generated cell-specific conditional DG-null
mice (Figure 1). We first examined the cerebellum of
PCP2-Cre/DG-null mice, where DG is conditionally de-
leted only in PCs, then in malpha6-Cre/DG-null mice,
where DG is conditionally deleted from GCs (Figure 2).
Dystroglycan is expressed in Purkinje cells (PCs) dur-
ing early postnatal cerebellar development [21], and DG-
positive puncta rimmed the PC somata and decorated
PC dendrites across the molecular layer in the adult
(P21) control cerebellum (Figure 2I). To assess whether
loss of DG in PC is adequate to cause migration defects,
we evaluated the histopathology of PCP2-Cre/DG-null
mice. The PCP2 promoter drives Cre expression in PCs
beginning on postnatal day 6 [23]. The brains of these
mice were grossly normal and many histologic sections
were free of histopathology (Figure 2G, H). After thorough
examination of several adult mice (n = 9), small, infre-
quent GC heterotopia were identified in the molecular
layer of each cerebellum (Figure 2C, F), just internal to an
intact glia limitans (Figure 2N). No disruptions of the glia
limitans or abnormalities of Bergmann glia orientation
were observed (Figure 2M, N) despite a nearly complete
loss of PC dystroglycan (Figure 2L).
Granule cells in the cerebellar cortex express DG dur-
ing their migration and lose expression during matur-
ation in the internal granule cell layer, suggesting that
expression of DG in GC may play a role during their mi-
gration [21]. To determine whether the loss of DG in
GC is sufficient to cause defects in GC migration, the
histopathology of the cerebellum was examined in
malpha6-Cre/DG-null mice, where DG is conditionally
deleted from GCs. The malpha6 promoter drives Cre
expression in GCs beginning at postnatal day 4 [24].
The brains of these animals (n = 7) were grossly nor-
mal (Figure 2D) and GC ectopia were not observed
(Figure 2E).Cerebellar growth in conditional dystroglycan-null mice
After establishing that neuronal DG is not necessary for
cerebellar histogenesis, we next evaluated the role of
glial DG in cerebellar development by using mice with
deletion of DG from both neuronal and glial cells. The
generation of the GFAP-Cre/DG-null and nestin-Cre/
DG-null mice has been previously described [5,7,8]. The
nestin promoter drives Cre expression in neuronal and
glial precursors as early as embryonic day 10.5, while the
ependyma and choroid plexus show no expression of the
nestin-Cre transgene [27]. The GFAP promoter drives
expression of Cre recombinase in radial glia, astrocytes,
ependyma and some neuronal cell types beginning at
embryonic day 13.5, but Purkinje cells and the choroid
plexus do not express GFAP-Cre [28]. The cerebella of
these mice were grossly normal; area measurements of
mid-sagittal sections from three different post-natal de-
velopmental time points showed no significant differ-
ences among the two mutant genotypes and their
littermate controls (Figure 3N). However, several ectopic
foci of granule cells were noted in the cerebella of both
GFAP-Cre and nestin-Cre conditional DG-null mice at
post-natal day 8 (Additional file 1: Figure S1) and day 16
(Figure 3H, I). Under higher magnification, these ectopic
cells appeared as clusters of non-migrating GCs that
remained in the EGL along some fissures and at the sur-
faces of some lobules, with at least some granule neuron
clusters migrating outward, through gaps in the basal
lamina, into the leptomeninges (Figure 3, K-M). By P21
this pattern of dysgenesis appeared as fused interlobular
fissures (Additional file 2: Figure S2). PCs in the mean-
while developed normally albeit for focal secondary ir-
regularities in dendritic arborization—some dendrites
reached across adjacent lobules at areas of discontinuous
basal lamina and GC ectopia (Additional file 3: Figure S3).
Dystroglycan expression in the developing cerebellum
To evaluate DG expression in the developing cerebel-
lum, mid sagittal sections from cerebella of nestin-Cre/
DG-null and littermate controls were double stained for
α-DG and laminin, a basement membrane protein and
ligand of αDG. DG was found to be concentrated at the
choroid plexus and the glia limitans from at least embry-
onic day 14 (E14.5), and it colocalized with laminin at
the glia limitans (Figure 4, A-C). Loss of DG in the
nestin-Cre/DG-null cerebellar anlage was confirmed at
E14.5 (Figure 4D). Laminin staining remained indistin-
guishable from control tissue, indicating an intact base-
ment membrane at this developmental time point. Soon
after birth (P0), laminin expression at the basal lamina
was absent in small foci (Figure 4E), but the extent of
abnormal laminin immunostaining spread as the cere-
bellum grew to P3 (Figure 4F). These breaks at the basal
lamina were found at the tips of cerebellar lobules and
Figure 2 Development in cerebellar neuron conditional dystroglycan-null mice. Macroscopic images of cerebellar morphology and
hematoxylin-eosin stained, mid-sagittal sections of adult cerebella from control (A, B), malpha6-Cre/DG-null (D, E), and PCP2-Cre/DG-null (G, H) mice.
Higher magnification of PCP2-Cre/DG-null mid-sagittal cerebellar section showing small heterotopia (C, F). Immunofluorescent staining of
α-dystroglycan (αDG) and glial fibrillary acidic protein (GFAP) (both green) in control (I, J) and PCP2-Cre/DG-null cerebella (L, M). Double staining of
laminin (LM; green) and neuronal nuclear protein (NeuN; red) in control (K) and PCP2-Cre/DG-null (N) cerebella. The cerebellum of both malpha6-Cre/
and PCP2-Cre/DG-null develop normally without gross malformations. Dystroglycan is expressed as puncta in Purkinje cells (double daggers; ‡) and
concentrated at glial endfeet (carets; ^) as well as blood vessels (right double angle brackets; ») in adult control cerebellum (I). In the PCP2-Cre/DG-null
mice, dystroglycan expression is greatly reduced in Purkinje cells, but its expression in glial cells remains unaltered at the glia limitans and surrounding
vessels (L). Loss of dystroglycan expression in the PCP2-Cre/DG-null does not affect Bergmann glia morphology (M) while causes in a mild degree of
GC ectopia (asterisks; *) immediately beneath an intact glia limitans (carets; ^) (N). DAPI (blue) was used as a nuclear counter stain. Scale bar: 20 μm.
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Figure 3 Cerebellar growth in brain-selective conditional dystroglycan-null mice. Cerebellar growth and development from P2, P7, and P16
in control (A, D, G), GFAP-Cre/DG-null (B, E, H), and nestin-Cre/DG-null (C, F, I). Normal lobules and fissures are indicated in the P16 control
cerebellum (G). In both nestin-Cre/DG-null and GFAP-Cre/DG-null mice, many lobule surfaces and fissures display abnormal numbers of ectopic
cells (asterisks; *) on the cerebellar surface or between two adjacent lobules. The resulting pathology appears as fused fissures and heterotopic
neurons. Basement membrane (arrows; ➛) at the glia limitans is continuous along the surface of controls (J). In nestin-Cre/DG-null cerebellum at
P2 (K), a cluster of granule neurons (asterisk; *) is seen outside the glia limitans (arrowhead; ➤). Similar, but more extensive, pathology is seen at
P7 (L) and P16 (M). Area measurements from mid-sagittal sections of control, GFAP-Cre/DG-null, and nestin-Cre/DG-null at P2, P7, and P16 (N).
Error bars denote standard error of the mean. n = 3 for each group. EGL = external granule cell; IGL = internal granule cell layer; Scale bar: 40 μm
(A-I), 40 μm (J-M).
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mice. In the developmentally mature control cerebellum
(P21), DG was expressed in Purkinje cells (PCs) in
addition to being concentrated at glial endfeet (Figure 4G).
Both neuronal and glial DG were lost in the nestin-Cre/
DG-null mice (Figure 4H), whereas the GFAP-Cre/DG-
null mice showed loss of DG from glial cell endfeet, while
maintaining expression in PCs (Figure 4I).
Disruptions at the glia limiting membrane correlate with
radial glia/Bergmann glia irregularities
Since DG is normally expressed and concentrated at glial
endfeet abutting the glia limitans, we next assessed the
morphology and orientation of radial glia (Bergmann
glia) in the absence of DG. Brain lipid binding protein(BLBP) and nestin were used as markers for radial
glia at P0 and P3 due to their expression early in cerebellar
development, whereas glial fibrillary acidic protein (GFAP)
was employed as a glial marker from P8 onward. Perlecan
and laminin are protein constituents of the extracellular
matrix that are ligands for α-DG. Radial glia (and later
Bergmann glia) are oriented in such a way that their
endfeet abut and form the glia limiting membrane under-
neath the basement membrane (Figure 5A, C). In the
nestin-Cre/DG-null cerebellum, small breaks at the glia
limitans that were first observed at P0 then became much
more visible at P3, and were accompanied by projections
of glial processes into these gaps (Figure 5B, D). Breaches
became exacerbated as the basement membrane, visualized
by both DG ligands (laminin and perlecan) and a non-DG
Figure 4 Expression of dystroglycan in the developing cerebellum. Immunofluorescent detection of α-dystroglycan (green; α-DG) and laminin
(red; LM) in the cerebellum of wild-type littermate controls at E14.5, P0, P3, and P21 (A-C, G), nestin-Cre/DG-null mice at matching developmental ages
(D-F, H), and GFAP-Cre/DG-null at P21 (I). DG is detectable at E14.5 and localizes with laminin (carets; ^) at the basement membrane overlying the
cerebellar primordium. In the absence of dystroglycan at E14.5 in the nestin-Cre/DG-null, the basement membrane appears to be intact, while small
discontinuities are noticeable at P0 and exacerbates by P3 (tildes). DG expression in Purkinje cells (double daggers; ‡) is retained in the GFAP-Cre/DG-null,
but not the nestin-Cre/DG-null cerebellum. DAPI (blue) was used as a nuclear counter stain. Asterisk (*) denotes ectopic cells. GCL = granule cell layer;
ML =molecular layer; PCL = Purkinje cell layer. Scale bar: 20 μm.
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Figure 5 Focal disruptions at the basement membrane are correlated with disorganized radial glia. Immunofluorescent detection of
perlecan (red) and brain-lipid binding protein (BLBP; green) in control (A, C) and nestin-Cre/DG-null cerebella (B, D) on the day of birth (P0) and at P3.
Immunofluorescent staining of glial fibrillary acidic protein (GFAP; red) and laminin (LM; green) in control (E) and nestin-Cre/DG-null littermate (F) at P8.
Immunostaining of β1-integrin (β1Itg, green) in control (G) and nestin-Cre/DG-null cerebella (H) at P21. In control cerebella, radial glia (Bergmann glia at
P8) endfeet abut an intact basement membrane (carets), forming the continuous glia limitans. In the absence of DG, disruptions at the basement
membrane are often found in areas of disorganized radial glia throughout development (tildes; ~). β1Itg is normally expressed in Bergmann glia in both
control and nestin-Cre/DG-null cerebella. However, β1Itg expression appears to be upregulated at areas of gliosis (asterism; ⁂), along with ectopic cells
(asterisks; *) and disrupted glia limitans (tildes; ~). DAPI (blue) was used as nuclear counter stain. Scale bar: 20 μm.
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became severely disrupted by P8, while Bergmann
glial endfeet projected into the gaps at the basementmembrane or retracted underneath the EGL (Figure 5F).
Electron microscopy studies confirmed the presence
of disrupted basement membrane, abnormally
Figure 6 Electron micrographs of breaks in the glia limitans. Electron micrographs are from nestin-Cre/DG-null cerebellum and littermate
control at P7. In panels A1 and B1 (duplicates of panels A and B), a subset of Bergmann glia processes are shaded in green while selected GCs are
colored in red and GCs undergoing mitosis are painted in blue. Panels C and D are higher magnification images of the regions of interest indicated by
arrows in panels A, A1, B, and B1. A continuous basal lamina (arrowheads) lines either side of this fissure in a control P7 cerebellum (C). A DG-null
littermate (D) displays a region containing abnormally organized radial glia processes and a largely absent basal lamina. Cells have migrated into the
fissure, leaving a fragment of the glia limitans (arrowheads) buried beneath heterotopic cells. Scale bar: 10 μm (A and B); 0.5 μm (C and D).
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the leptomeninges of nestin-Cre/DG-null cerebella
(Figure 6). Additionally, β1 integrin (β1itg), a lamininreceptor, was expressed in Bergmann glia and concen-
trated at glial endfeet (Figure 5G); a compensatory change
in β1itg expression was not observed at the glia limitans
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gliosis did show high levels of expression (Figure 5H). Fur-
thermore, we observed reactive gliosis at sites with
disrupted basement membrane in developmentally more
mature mice (Figure 7). Taken together, our data indicate
that the expression of DG in glial cells is important for
their morphological development as well as the integrity
of the surface basement membrane during cerebellar
growth.
We further evaluated the expression of proteins known
to associate with DG and the dystrophin-glycoprotein
complex (DGC) in glial cells, namely aquaporin 4 (AQP4)
and potassium inward rectifying channel 4.1 (Kir4.1). The
membrane pore protein AQP4 comprising the major
water channels in brain is clustered together with the
DGC via interaction between AQP4 and α-syntrophin
[29], which in turn binds to dystrophin and β-DG. In the
cerebellum, AQP4 concentrated at the glia limitans in
control (Additional file 5: Figure S5A, B) but was reduced
at P8 and lost by P16 in the nestin-Cre/DG-null mice
(Additional file 5: Figure S5D, E). Whether loss of AQP4
at glial endfeet in these mice causes other pathologic phe-
notypes remains to be investigated, but AQP4-null mice
show no brain morphological defects, suggesting that the
presence of ectopic cells in the nestin-Cre/DG-null mice
is independent from AQP4. Kir4.1 is enriched at Müller
glial endfeet abutting the inner limiting membrane in the
retina; defects in Kir4.1 clustering and retinal physiologyFigure 7 Disruptions in the glia limitans are associated with reactive
(LM; green) in nestin-Cre/DG-null cerebellum at P3 (A). Immunofluorescent
green) in nestin-Cre/DG-null cerebella at P8 (B), P16 (C), and P21 (D). Reac
membrane, demarcated by laminin staining, is severely disrupted or mostlyhave been demonstrated in the nestin-Cre/DG-null mice
[6]. In the cerebellum, Kir4.1 is expressed in the molecular
layer, but is not concentrated at the glia limitans. Expres-
sion of Kir4.1 was indistinguishable between nestin-Cre/
DG-null and littermate control (Additional file 5: Figure
S5C, F), indicating that Kir4.1 localization in the cerebel-
lum, unlike in the retina, is not dependent on DG.
Proliferation and migration of postnatal granule cells
To assess GC proliferation immediately after birth (P0)
and again at the peak of cerebellar growth (P8), 5-
bromodeoxyuridine (BrdU) was acutely given to mice
30 minutes prior to sacrifice, and cerebellar tissues were
evaluated in cryosections using an antibody against
BrdU. BrdU strongly labeled the EGL at P0 and the
outer proliferative EGL (EGLo) at P8 in the control cere-
bellum (Figure 8A, F). The nestin-Cre/DG-null mice at
P0 showed a similar expression profile of BrdU positive
cells and were not significantly different from the
control tissues (Figure 8B, I). At P8, ectopic GCs la-
beled by neuronal nuclei protein (NeuN) and residing in
areas of highly disruptive basal lamina (Figure 8E, H) have
stopped proliferating. Quantitative analysis showed a
significantly reduced number of BrdU-positive cells
in regions with a disrupted basal lamina (Figure 8J)
compared to cells beneath an intact basement mem-
brane (Figure 8G) and compared to control cerebel-
lum (Figure 8F).astrocytes. Immunofluorescent detection of nestin (red) and laminin
staining of glial fibrillary acidic protein (GFAP; red) and laminin (LM;
tive astrocytes (asterisms;⁂) dominate areas where the basement
absent. Scale bar: 20 μm.
Figure 8 (See legend on next page.)
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(See figure on previous page.)
Figure 8 Proliferation of granule cells. Immunofluorescent detection of 5-bromodeoxyuridine (BrdU; red) in cerebella of control (A) and
nestin-Cre/DG-null mice (B) at P0. Immunofluorescent detection of neuronal nuclear protein (NeuN; red) and laminin (LM; green) in cerebella of
control (C) and nestin-Cre/DG-null mice (D, E) at P8. Immunofluorescent detection of 5-bromodeoxyuridine (BrdU; red) and neuronal nuclear
protein (NeuN; green) in control (F) and nestin-Cre/DG-null cerebella at P8 (G, H). Quantitative analysis of GC proliferation at P0 (I) and P8 (J).
GC proliferation appears to be normal in control and nestin-Cre/DG-null cerebella at birth. However, a reduction in the number of BrdU positive
cells was detected at areas of disrupted basement membrane in the nestin-Cre/DG-null cerebellum at P8. Carets (^) denote the intact basement
membrane; tildes (~) indicate areas of disrupted basement membrane; asterisks (*) represent ectopic GCs. Error bars denote standard error of the
mean. Asterisk in panel J denotes P < 0.05. n = 3 for each group described in bar graphs. b.m. = basement membrane; EGLi = inner external
granule cell layer; EGLo = outer external granule cell layer. Scale bar: 20 μm.
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half of cerebellar histogenesis, pulse-chase migration stud-
ies were performed by BrdU administration at P8 and
evaluation of cerebellar tissues at P16. In the control mice,
the vast majority of cells labeled at P8 were found within
the IGL at P16. In contrast, many of these later-born GCs
remained at the cerebellar surface within ectopia of the
nestin-Cre/DG-null cerebellum (Figure 9).
We additionally evaluated expression levels of sonic
hedgehog (Shh)—a critical morphogen involved in the
patterning of many brain structures during development
—at P8 and P16 to confirm that GC proliferation and
migration defects were independent from Shh path-
ways. Shh expression in the cerebellum was found to be
comparable between nestin-Cre/DG-null and control lit-
termates (Additional file 4: Figure S4).
In comparing the degree of glia limitans pathology and
ectopic GC over entire mid-sagittal sections, sparing of
lobules IV-V and VI was noted (Additional file 6: Table
S1). A quantitative comparison of lobules IV-V and IX was
carried out in nestin-Cre/DG-null mice (Figure 9G), and
complete mapping of mid-sagittal sections was performed
in both nestin-Cre/DG-null and GFAP-Cre/GFAP-null
mice (Figure 10A). The spatially asymmetric pathology
had the greatest degree of sparing limited to the tips of
lobules IV-V; the tip of lobule VI was spared to a lesser de-
gree. Fissures between these lobules were not spared in
comparison to any other fissures. This analysis also
showed gradually more severe pathology over an increas-
ingly larger surface area of the developing cerebellar cortex
in both nestin-Cre/ and GFAP-Cre/DG-null mice, with the
former showing a somewhat more severe phenotype at
each postnatal age evaluated. Evaluation of parasagittal
sections showed that glia limitans and GC pathology ex-
tended laterally to involve the cerebellar hemispheres in
both models. The spatial distribution of pathology away
from the midline in one nestin-Cre/DG-null cerebellum
was mapped (Figure 10B).
Characterization of ectopic granule cells at sites of
disrupted basal lamina
To assess GC maturation, the expression of several markers
was evaluated in the course of post-natal cerebellar devel-
opment. The inner, post-mitotic, pre-migratory zone of theEGL (EGLi) was labeled with transient axonal glycoprotein
1 (tag1) and microtubule-associated protein 2 (MAP2) at
P8 (Figure 11A, C). Tag1 is down-regulated as GCs begin
to migrate inward across the molecular layer (ML) to settle
in the internal granule cell layer (IGL); tag1-null mice
displayed a mild GC migratory defect [30]. MAP2 is a cyto-
skeletal protein that plays essential roles in a number of cel-
lular developmental processes, including neuronal
morphogenesis. In the nestin-Cre/DG-null cerebellum,
tag1-positive cells were visible within the EGLo as ectopia
bridging between adjacent lobules (Figure 11B); MAP2
showed similar expression to tag1 in small foci of ectopic
GCs (Figure 11D). Meanwhile, the paired box 6 (pax6)
transcription factor, a DNA-binding protein crucial for
CNS development, was shown in cells of the EGL under-
neath an intact basement membrane (Figure 11E). GCs
from Pax6-null mice, due to defect in cytoskeletal
organization and polarization, do not form leading edges
and migrate in random directions instead of radially inward
[31]. The expression level of pax6 in ectopic cells, at sites
of disrupted basement membrane, was similar to that of
surrounding cells and in control (Figure 11H). These data
indicate that the cellular machinery responsible for
GC maturation is largely unperturbed in the nestin-Cre/
DG-null cerebellum, insofar as we have demonstrated,
and that the cause of ectopia is seemingly due to ab-
errant glial organization and reactive gliosis rather
than GC-intrinsic abnormality. In support of this in-
terpretation, GC ectopia at later developmental stages
(P16 and P21) expressed markers of mature neurons nor-
mally found in the granule cell layer (GCL), for instance
NeuN and GABAA receptor α6 (GABARA6) (Figure 11I,
J).
Discussion
In addition to dystrophic skeletal muscle pathology, a
spectrum of developmental brain abnormalities are asso-
ciated with congenital muscular dystrophies caused by
mutations in genes involved in the glycosylation path-
ways of dystroglycan [32,33]. Cysts, hypoplasia, or dys-
plasia are among the prominent cerebellar pathologic
features frequently observed in these dystroglycanopathy
patients [2,3]. Dystroglycan is expressed in important
cell types of the cerebellum, including Bergmann glia,
Figure 9 Migration of granule cells. Immunofluorescent detection of 5-bromodyoxyuridine (BrdU; red) and neuronal nuclear protein (NeuN; green)
in cerebella of control (A-C) and nestin-Cre/DG-null (D-F) mice at P16. Quantitative analysis of GC migration from P8 to P16 (G). Representative
schematic of lobules IV-V and IX from a control (H, J) and nestin-Cre/DG-null (I, K). GC from the EGL proliferate, differentiate and migrate inward to form
the GCL. In the nestin-Cre/DG-null mice, some of these cells undergo differentiation but remain at the cerebellar surface or locate within fissures instead
of migrating to their proper destination in the IGL. The surface of lobule IV-V is not affected in the nestin-Cre/DG-null cerebellum. Asterisks (*) indicate
ectopic GCs (D-F). Error bars denote standard error of the mean. Asterisks in the graph denote P < 0.05. n = 3 for each group described in bar graphs. GC
= granule cell; GCL = granule cell layer; IGL = internal granule cell layer. Scale bar: 20 μm.
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http://www.actaneurocomms.org/content/1/1/58GCs, and PC [21,22]. In this study, we show that glial
DG, via interaction with the ECM at the glia limitans, is
critical for normal cerebellar histogenesis, while neur-
onal DG is largely unnecessary.
The predominant phenotype observed in our conditional
DG knockout models of cerebellar dysplasia is widespread
GC migration errors, corroborated by BrdU pulse-chase la-
beling; a subset of GCs expressing markers of mature neu-
rons remain on the EGL surface, at sites of disrupted glia
limitans and aberrant glial organization as well as reactive
gliosis. These phenotypes are remarkably similar to those
described in previous cerebellar development studies ofβ1Itg-null mice [26]. β1Itg is another laminin receptor
that plays a role in GC precursor proliferation via its inter-
action with sonic hedgehog (Shh) and laminin. In the ab-
sence of β1Itg, GCs lose contact with the basement
membrane, exit the cell cycle, and differentiate prema-
turely [26,34]. Similar to β1Itg-null mice, our DG-null
mice showed reduced GC proliferation at areas of highly
disrupted glia limitans. However, further investigation
showed relatively normal Shh expression in the absence
of DG, and that Shh is even present in areas of ec-
topic GC (Additional file 4: Figure S4). Additionally, β1Itg
itself is unable to compensate for the loss of DG, as its
Figure 10 Neuronal migration errors are not spatially uniform. GC migration errors discerned from H&E-stained paraffin sections of nestin-Cre/
DG-null and GFAP-Cre/DG-null cerebella (see Figure 3 and Additional file 6: Table S1) were plotted in mid-sagittal maps (A). Darker shading reflects a
higher proportion of samples displaying pathology in a specific region of the cerebellum. Nestin-Cre/DG-null cerebella display more widespread
clusters of ectopic GC. The surface of lobules IV-V, and an area on the surface of lobule VI, are relatively spared. A surface map of GC migration errors
from a representative nestin-Cre/DG-null cerebellum at P8 is illustrated (B). Pathologic clusters of non-migrating GC exist over a vast area of lobule
surfaces and fissures at every parasagittal level examined.
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Cre/DG-null cerebellum (Figure 5H). Moreover, CNS
deletion of integrin-linked kinase, an intracellular effector
of β1Itg, results in abnormal cerebellar development asso-
ciated with defects in glial process outgrowth, meningeal
basement membrane assembly, and GC proliferation
[35,36]. In contrast, deletion of the cytoplasmic domain
of β-DG did not result in disruptions of the glia
limitans while displaying a mild cerebellar migration
defect [7]. This suggests that unlike β1Itg, whose
intracellular signals are critical for cerebellar develop-
ment, the extracellular interactions of α-DG are most
crucial for cerebellar development.
In fact, the mucin domain of α-DG is decorated with
LARGE-dependent phosphorylated O-mannosyl glycans
that are responsible for α-DG high affinity binding activ-
ity [37,38]. The Largemyd mice harbor a spontaneous muta-
tion the Large gene, which results in hypoglycosylated
α-DG and loss of ligand binding [4,39]. These mice de-
velop many of the brain malformations associated with se-
vere forms of dystroglycanopathy, including disruption
of the basement membrane and aberrant neuronal migra-
tion in the cerebrum and cerebellum [4,40,41]. A mouse
model harboring the T192M mutation in DG shows im-
paired LARGE-mediated modification of phosphorylated
O-mannosyl glycans on α-DG and reduced ligand-binding
affinity [42]. However, these mice show no gross structural
abnormality in the brain, suggesting that the residual
ligand-binding activity of α-DG is sufficient for normalbrain laminar development. Taken together, the patho-
logical resemblance between the Largemyd, nestin-Cre/DG-
null, and GFAP-Cre/DG-null mice, and the lack of brain
malformation in the T192M mice further support the hy-
pothesis that extracellular interactions of α-DG in glia are
critical for basal lamina integrity, a proper glial scaffold,
and normal neuronal migration.
Although the distribution of GC ectopia was similar
between GFAP-Cre/DG-null and nestin-Cre/DG-null
mice, the severity of pathology was greater in nestin-
Cre/DG-null cerebella. Since GFAP-Cre/DG-null mice
retain expression of DG in PCs, it is possible that DG
expression in PCs partially compensates for the loss of
DG expression in other cell types or that PC DG has a
function in GC migration. During their migration
through the ML, GCs extend parallel fibers and make
synaptic contacts with dendritic arbors of PC, and it has
been suggested that adhesion molecules mediate the
contacts between migrating neurons and PCs helping to
direct migrating GCs into the IGL [43]. DG may be one
of the adhesion molecules that mediates these interac-
tions. However, genetic experiments using PCP2-Cre/DG-
null mice revealed only small GC heterotopia compared
to nestin-Cre or GFAP-Cre mice, showing that PC DG
has a very minor role in cerebellar histogenesis. Alterna-
tively, the mild phenotype observed in the PCP2-Cre/DG-
null mice could be attributed to the small amount of
residual DG expressed in PCs or the relatively late
loss of DG during cerebellar development. While the
Figure 11 Ectopic neurons are present at areas of disrupted basement membrane. Immunofluorescent detection of transient axonal
glycoprotein 1 (TAG1), microtubule-associated protein 2 (MAP2), paired box 6 (pax6), neuronal nuclear protein (NeuN), and GABAA receptor α6
(GABARA6) (all red) and laminin (LM; green) in control cerebella at P8 (A, C, E), P16 (F), P21 (G) and in age-matched nestin-Cre/DG-null (B, D, H-J).
At P8, the EGL in the control cerebellum consists of an outer and inner layer, corresponding to proliferating and post-mitotic GC, respectively. Toward the
end of cerebellar development at P16, the EGL ceases to exist as differented GCs migrate inward to form the IGL. In the absence of dystroglycan, ectopic
GC differentiate yet remain trapped at the cerebellar surface where the basement membrane is highly disrupted. DAPI (blue) was used as a nuclear
counter stain. Carets (^) denote the continuous basement membrane; tildes (~) indicate areas of disrupted basement membrane; asterisks (*) represent
ectopic cells. Solid lines in panels E-G demarcate the continuous basal lamina. EGLi = inner external granule cell layer; EGLo = outer external granule cell
layer. GCL = granule cell layer; IGL = internal granule cell layer; ML =molecular layer. Scale bar: 20 μm.
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after birth and continues until P16, the PCP2 transgene is
not expressed until P6 and does not become robust until
P16 [23]. Similar experiments with malpha6-Cre/DG-null
mice failed to discern a role for DG expression in GC.
The malpha6 transgene is expressed in GC precursors
during the peak of GC migration [24], yet no ectopic GC
were observed in these mice.Mapping the glia limitans and ectopic granule cell
pathology in nestin-Cre and GFAP-Cre/DG null mice
demonstrated a spatial heterogeneity along the glia
limitans that has not previously been identified. Al-
though our studies showed that perlecan, collagen IV,
and laminin are all similarly perturbed at areas of
disrupted basal lamina and all preserved at the surface
of lobules IV-V and VI, we hypothesize that variation in
Figure 12 (See legend on next page.)
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(ECM) proteins could explain the spatial heterogeneity
of pathology observed in the nestin-Cre/DG null andGFAP-Cre/DG null mice. It is well established that
expression of ECM components changes as basement
membranes mature and likely involves the initial
(See figure on previous page.)
Figure 12 Working model of abnormal cerebellar development in dystroglycanopathies. In control mice at E14.5 (A), the rhombic lip gives
rise to granule cell precursors (GCPs), which migrate across the cerebellar surface to form a secondary zone of neurogenesis, the EGL. Radial
glia from the vz extend their endfeet to the cerebellar surface, forming the glia limitans complete with basement membrane. In the nestin-Cre/
DG-null mice (B), DG is lost by E14.5 in all cells derived from the neuroepithelium; the cerebellar basement membrane at this time point remains
intact. As cells continue to proliferate, the EGL is further divided into two zones: the outer EGL consisting of still-proliferating GCPs, and the inner
EGL consisting of post mitotic GCs. GCs from the inner EGL will migrate inward, along radial glia, past the PC layer to settle in the IGL. The
cerebellum at P8—the peak of post natal development—is illustrated in panel C. In the nestin-Cre/DG-null mice (D), small breaks at the
basement membrane are detectable on the day of birth then exacerbate. A failure of basement membrane assembly, basement membrane
maintenance, and/or glial end foot-basement membrane adhesion, result in aberrant radial glia/Bergmann glia organization as the cerebellum
grows. Post mitotic GCs from the inner EGL fail to migrate and remain trapped at the cerebellar surface due to lack of glial scaffolds or alterations
in the local environment such as astrogliosis (red stellate cells). The EGL ceases to exist toward the end of normal post-natal development
(P16, E). In the nestin-Cre/DG-null mice (F), ectopic GCs are prominent at the cerebellar surface where the basement membrane is disrupted and
Bergmann glia are highly unorganized. Despite their failure to migrate, these ectopic neurons express markers of differentiated GCs. Reactive
gliosis is prominent within these regions of disrupted glia limitans and heterotopic GC.
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polymerization of further laminin chains and the
cross-linking of the laminin superstructure with other
ECM components [44]. Alternatively, there may be
spatial and temporal differences in the glial endfeet
receptors for ECM proteins during development, even
though no spatial heterogeneity in the expression of
dystroglycan or β1-integrin was observed in our work. Ra-
ther than viewing basement membranes within a given tis-
sue as homogenous structures changing uniformly over
time, further exploration of their assembly and mainten-
ance as spatially heterogeneous structures is warranted.
Conclusions
In summary, we report that radial glia/Bergmann glia
DG is essential for cerebellar development and propose
a working model depicted in Figure 12. Dystroglycan, via
its α-subunit, acts as an extracellular receptor for the
ECM proteins that comprise the basement membrane
(BM) covering the cerebellar surface to which the glial
endfeet abut. Normal expression of matrix receptor pro-
teins (i.e. DG and integrins) provide a platform for lam-
inin binding and polymerization, as well as subsequent
recruitment and cross-linking of other laminin-binding
components to the self-assembled basal lamina. During
the rapid expansion of cerebellar volume in the postnatal
period, properly anchored glial endfeet provide not only
a stabile platform on which BM components continue
their assembly, but also maintain the radial scaffolding
for neuronal migration. Insofar as GC progenitors from
the EGL continue to proliferate, differentiate, and mi-
grate radially inward over a protracted period of time,
the integrity of the BM covering the expanding cerebellar
cortex is critical for proper development. In the absence
of functional α-DG, BM components may still be capable
of assembling to a certain extent due to the presence of
other cellular receptors (i.e. integrins). However, the lack
of sufficient ligand-binding sites on the glial cell surface
impairs BM stability. In fact, agrin and perlecan, both ofwhich bind to laminin and α-DG, form collateral cross-
linking bridges between the laminin and collagen net-
works, effectively compacting and stabilizing the BM. Loss
of these interactions with α-DG appears sufficient to alter
the biomechanical properties of the BM. The biomechan-
ical stability of a different central nervous system base-
ment membrane, the inner limiting membrane formed by
Müller glial endfeet in the retina, was severely weakened
in the Largemyd and POMGnT1-null mice [45]. We
hypothesize that a similarly compromised BM on the sur-
face of the cerebellum is likely to fracture during the rapid
volumetric expansion of postnatal development, leading
to reactive gliosis and the loss of Bergmann glial scaffolds.
Collectively, this pathology is responsible for the granule
cell migration abnormalities observed here and may be
largely responsible for the cerebellar dysplasia observed in
dystroglycanopathy patients.Additional files
Additional file 1: Figure S1. Regional heterogeneity in P8 cerebella.
Lobules I, II, and III exhibit obliteration of their normal borders in nestin-Cre
/DG-null (B) and, to a lesser extent, GFAP-Cre/DG-null (C) cerebella. The
fissures bordering lobules IV and V showed extensive clusters of abnormally
migrating granule cells in the nestin-Cre/DG-null cerebellum (E), while that
of GFAP-Cre/DG-null (F) display subtle abnormalities. However, the surfaces
of these lobules remained normal. In contrast, lobule IX displayed abnormal
granule cells across its entirety in both nestin-Cre/ and GFAP-Cre/DG-null
mice, with substantial fusion of between lobule VIII and IX. Asterisks (*)
denote ectopic cells. Scale bar: 50 μm.
Additional file 2: Figure S2. Fusion between lobules III and IV.
H&E stainings of a control (A and A1) and nestin-Cre/DG-null cerebellum
(B and B1) at post-natal day 21. Immunofluorescent staining of glial
fibrilary acidic protein (GFAP, red) and laminin (LM, green) of the same
control (C and C1) and nestin-Cre/DG-null cerebellum (D and D1). The
basal lamina (green) was continuous between lobule III and IV in control
cerebellum while Bergmann glial endfeet (red) abutted the glia limitans.
In the nestin-Cre/DG-null cerebellum, a large break at the basal lamina
(tildes; ~) was infiltrated by over extending Bergmann glial endfeet.
Asterisks (*) indicate similar regions on all images. Scale bar: 20 μm.
Additional file 3: Figure S3. Abnormal development of Purkinje cells.
Immunostaining of calbindin (red) in adult control (A) nestin-Cre/DG-null
cerebella (B and C). Purkinje cell somata (double daggers; ‡) formed a
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http://www.actaneurocomms.org/content/1/1/58single layer above the GCL while their dendrites branched across the ML
towards the cerebellar surface. However, PC dendrites in the nestin-Cre
/DG-null appeared to reach across to adjacent lobules in areas of
heterotopia and disrupted glia limitans. Daggers (†) denote abnormal PC
dendrites. GCL = granule cell layer; ML =molecular layer; PCL = Purkinje
cell layer. Scale bar: 20 μm.
Additional file 4: Figure S4. Expression of sonic hedgehog (Shh) in the
absence of dystroglycan. Immunofluorescent labeling of laminin or
collagen IV (ColIV; red) and sonic hedgehog (Shh; green) in the developing
cerebellum of wild-type (A-C, J) and nestin-Cre/DG-null (D-I, K, L) mice at P8
and P16. Shh expression in the cerebellum is not altered in the absence of
dystroglycan. Carets (^) denote the intact basement membrane; tildes (~)
indicate areas of disrupted basement membrane; asterisks (*) represent
ectopic GCs. Scale bar = 50 μm.
Additional file 5: Figure S5. Expression of AQP4 and Kir4.1.
Immunodetection of collagen IV, aquaporin 4, and potassium inward
rectifying channel 4.1 (ColIV, AQP4, and Kir4.1; all green) in control
(A-C; G-I) and in nestin-Cre/DG-null cerebella (D-E; J-L) at P8 and P16.
DAPI (blue) was used as nuclear counter stain. AQP4 is enriched at glial
endfeet abutting the basement membrane (labeled with ColIV) in control
cerebella; this concentration of AQP4 is reduced in the nestin-Cre/DG-null
at P8 and lost by P16. Kir4.1 is expressed throughout the molecular layer
of the cerebellum at P16; its expression is indistinguishable between
nestin-Cre/DG-null and littermate control. Carets (^) denote the intact
basement membrane; tildes (~) indicate areas of disrupted basement
membrane; asterisks represent ectopic GCs. Scale bar = 50 μm.
Additional file 6: Table S1. Area-specific incidence of pathology.
Lobules IV and V displayed pathological breaks in the glia limitans rarely
when compared to all other lobules, including IX. However, the fissures
bordering IV and V were frequently abnormal.
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